Hydroxyfasudil

DB04707

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 307.368
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

113 Data
Nicotine The risk or severity of adverse effects can be increased when Hydroxyfasudil is combined with Nicotine.
Mecamylamine The risk or severity of adverse effects can be increased when Hydroxyfasudil is combined with Mecamylamine.
Pentolinium The risk or severity of adverse effects can be increased when Hydroxyfasudil is combined with Pentolinium.
Trimethaphan The risk or severity of adverse effects can be increased when Hydroxyfasudil is combined with Trimethaphan.
Hexamethonium The risk or severity of adverse effects can be increased when Hydroxyfasudil is combined with Hexamethonium.
Cyclopentamine The risk or severity of adverse effects can be increased when Hydroxyfasudil is combined with Cyclopentamine.
Methotrexate The protein binding of Methotrexate can be increased when combined with Hydroxyfasudil.
Ketoprofen The risk or severity of adverse effects can be increased when Ketoprofen is combined with Hydroxyfasudil.
Dexketoprofen The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Hydroxyfasudil.
Cyclosporine The risk or severity of renal failure can be increased when Hydroxyfasudil is combined with Cyclosporine.
Insulin human The risk or severity of hypoglycemia can be increased when Hydroxyfasudil is combined with Insulin human.
Insulin lispro The risk or severity of hypoglycemia can be increased when Hydroxyfasudil is combined with Insulin lispro.
Insulin glargine The risk or severity of hypoglycemia can be increased when Hydroxyfasudil is combined with Insulin glargine.
Insulin pork The risk or severity of hypoglycemia can be increased when Hydroxyfasudil is combined with Insulin pork.
Troglitazone The therapeutic efficacy of Troglitazone can be increased when used in combination with Hydroxyfasudil.
Glimepiride The therapeutic efficacy of Glimepiride can be increased when used in combination with Hydroxyfasudil.
Sulfisoxazole The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Hydroxyfasudil.
Disopyramide The therapeutic efficacy of Disopyramide can be increased when used in combination with Hydroxyfasudil.
Acarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Hydroxyfasudil.
Metformin The therapeutic efficacy of Metformin can be increased when used in combination with Hydroxyfasudil.
Sulfadiazine The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Hydroxyfasudil.
Rosiglitazone The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Hydroxyfasudil.
Acetohexamide The therapeutic efficacy of Acetohexamide can be increased when used in combination with Hydroxyfasudil.
Quinine The therapeutic efficacy of Quinine can be increased when used in combination with Hydroxyfasudil.
Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Hydroxyfasudil.
Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Hydroxyfasudil.
Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Hydroxyfasudil.
Pentamidine The therapeutic efficacy of Pentamidine can be increased when used in combination with Hydroxyfasudil.
Mifepristone The therapeutic efficacy of Mifepristone can be increased when used in combination with Hydroxyfasudil.
Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Hydroxyfasudil.
Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Hydroxyfasudil.
Phenformin The therapeutic efficacy of Phenformin can be increased when used in combination with Hydroxyfasudil.
Sulfamethoxazole The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Hydroxyfasudil.
Glyburide The therapeutic efficacy of Glyburide can be increased when used in combination with Hydroxyfasudil.
Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Hydroxyfasudil.
Gliclazide The therapeutic efficacy of Gliclazide can be increased when used in combination with Hydroxyfasudil.
Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Hydroxyfasudil.
Pioglitazone The therapeutic efficacy of Pioglitazone can be increased when used in combination with Hydroxyfasudil.
Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Hydroxyfasudil.
Gliquidone The therapeutic efficacy of Gliquidone can be increased when used in combination with Hydroxyfasudil.
Mitiglinide The therapeutic efficacy of Mitiglinide can be increased when used in combination with Hydroxyfasudil.
Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Hydroxyfasudil.
Sunitinib The therapeutic efficacy of Sunitinib can be increased when used in combination with Hydroxyfasudil.
Exenatide The therapeutic efficacy of Exenatide can be increased when used in combination with Hydroxyfasudil.
Mecasermin The therapeutic efficacy of Mecasermin can be increased when used in combination with Hydroxyfasudil.
Pramlintide The therapeutic efficacy of Pramlintide can be increased when used in combination with Hydroxyfasudil.
Glisoxepide The therapeutic efficacy of Glisoxepide can be increased when used in combination with Hydroxyfasudil.
Insulin aspart The risk or severity of hypoglycemia can be increased when Hydroxyfasudil is combined with Insulin aspart.
Insulin detemir The risk or severity of hypoglycemia can be increased when Hydroxyfasudil is combined with Insulin detemir.
Insulin glulisine The risk or severity of hypoglycemia can be increased when Hydroxyfasudil is combined with Insulin glulisine.
Glymidine The therapeutic efficacy of Glymidine can be increased when used in combination with Hydroxyfasudil.
AICA ribonucleotide The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Hydroxyfasudil.
Buformin The therapeutic efficacy of Buformin can be increased when used in combination with Hydroxyfasudil.
Vildagliptin The therapeutic efficacy of Vildagliptin can be increased when used in combination with Hydroxyfasudil.
Voglibose The therapeutic efficacy of Voglibose can be increased when used in combination with Hydroxyfasudil.
NN344 The risk or severity of hypoglycemia can be increased when Hydroxyfasudil is combined with NN344.
AMG-222 The therapeutic efficacy of AMG-222 can be increased when used in combination with Hydroxyfasudil.
Bisegliptin The therapeutic efficacy of Bisegliptin can be increased when used in combination with Hydroxyfasudil.
Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Hydroxyfasudil.
Dapagliflozin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Hydroxyfasudil.
Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Hydroxyfasudil.
Liraglutide The therapeutic efficacy of Liraglutide can be increased when used in combination with Hydroxyfasudil.
Gosogliptin The therapeutic efficacy of Gosogliptin can be increased when used in combination with Hydroxyfasudil.
Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Hydroxyfasudil.
Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Hydroxyfasudil.
Glibornuride The therapeutic efficacy of Glibornuride can be increased when used in combination with Hydroxyfasudil.
Benfluorex The therapeutic efficacy of Benfluorex can be increased when used in combination with Hydroxyfasudil.
Empagliflozin The therapeutic efficacy of Empagliflozin can be increased when used in combination with Hydroxyfasudil.
Albiglutide The therapeutic efficacy of Albiglutide can be increased when used in combination with Hydroxyfasudil.
Dulaglutide The therapeutic efficacy of Dulaglutide can be increased when used in combination with Hydroxyfasudil.
Lobeglitazone The therapeutic efficacy of Lobeglitazone can be increased when used in combination with Hydroxyfasudil.
Netoglitazone The therapeutic efficacy of Netoglitazone can be increased when used in combination with Hydroxyfasudil.
Rivoglitazone The therapeutic efficacy of Rivoglitazone can be increased when used in combination with Hydroxyfasudil.
Ciglitazone The therapeutic efficacy of Ciglitazone can be increased when used in combination with Hydroxyfasudil.
Lixisenatide The therapeutic efficacy of Lixisenatide can be increased when used in combination with Hydroxyfasudil.
Insulin beef The risk or severity of hypoglycemia can be increased when Hydroxyfasudil is combined with Insulin beef.
Insulin degludec The risk or severity of hypoglycemia can be increased when Hydroxyfasudil is combined with Insulin degludec.
Insulin peglispro The risk or severity of hypoglycemia can be increased when Hydroxyfasudil is combined with Insulin peglispro.
Insulin tregopil The risk or severity of hypoglycemia can be increased when Hydroxyfasudil is combined with Insulin tregopil.
Ipragliflozin The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Hydroxyfasudil.
Dutogliptin The therapeutic efficacy of Dutogliptin can be increased when used in combination with Hydroxyfasudil.
Allicin The therapeutic efficacy of Allicin can be increased when used in combination with Hydroxyfasudil.
Tofogliflozin The therapeutic efficacy of Tofogliflozin can be increased when used in combination with Hydroxyfasudil.
Ertugliflozin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Hydroxyfasudil.
2,4-thiazolidinedione The therapeutic efficacy of 2,4-thiazolidinedione can be increased when used in combination with Hydroxyfasudil.
Teneligliptin The therapeutic efficacy of Teneligliptin can be increased when used in combination with Hydroxyfasudil.
Omarigliptin The therapeutic efficacy of Omarigliptin can be increased when used in combination with Hydroxyfasudil.
Carmegliptin The therapeutic efficacy of Carmegliptin can be increased when used in combination with Hydroxyfasudil.
Gemigliptin The therapeutic efficacy of Gemigliptin can be increased when used in combination with Hydroxyfasudil.
Anagliptin The therapeutic efficacy of Anagliptin can be increased when used in combination with Hydroxyfasudil.
Evogliptin The therapeutic efficacy of Evogliptin can be increased when used in combination with Hydroxyfasudil.
Sotagliflozin The therapeutic efficacy of Sotagliflozin can be increased when used in combination with Hydroxyfasudil.
Balaglitazone The therapeutic efficacy of Balaglitazone can be increased when used in combination with Hydroxyfasudil.
Remogliflozin etabonate The therapeutic efficacy of Remogliflozin etabonate can be increased when used in combination with Hydroxyfasudil.
Carbutamide The therapeutic efficacy of Carbutamide can be increased when used in combination with Hydroxyfasudil.
Guar gum The therapeutic efficacy of Guar gum can be increased when used in combination with Hydroxyfasudil.
Metahexamide The therapeutic efficacy of Metahexamide can be increased when used in combination with Hydroxyfasudil.
Semaglutide The therapeutic efficacy of Semaglutide can be increased when used in combination with Hydroxyfasudil.
Taspoglutide The therapeutic efficacy of Taspoglutide can be increased when used in combination with Hydroxyfasudil.
Englitazone The therapeutic efficacy of Englitazone can be increased when used in combination with Hydroxyfasudil.

Target Protein

Chloride channel protein 2 CLCN2
Rho-associated protein kinase 1 ROCK1
cAMP-dependent protein kinase catalytic subunit alpha PRKACA
cAMP-dependent protein kinase inhibitor alpha PKIA

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul